Three years after COVID, endothelial dysfunction still explains why exercise feels impossible
Long COVID research has spent years chasing the 'why' behind symptoms that look similar but behave differently in every patient.
This week, the field got sharper on mechanisms — and at least one small trial offered a treatment signal worth watching.
The Heart Looks Fine. The Blood Vessels Don't. 🩺
- A case-control study followed Long COVID patients roughly three years after infection and found their hearts were functionally normal by standard echocardiography — but their blood vessels weren't. Endothelial function, measured by how well the brachial artery dilates under increased blood flow, was significantly impaired compared to healthy controls.
- Exercise capacity told the same story: Long COVID participants hit lower peak oxygen uptake and fatigued earlier, and those numbers tracked closely with how impaired their vessel function was.
- The heart isn't the bottleneck. The peripheral vasculature is — and it hasn't recovered even after three years.
Why it matters: This shifts the clinical frame. If exercise intolerance in Long COVID is primarily a vascular problem rather than a cardiac one, the diagnostic and treatment targets change accordingly.
Key Findings
VR Exercise Outperformed Conventional Rehab on Fatigue — Barely, but Meaningfully 🎮
- In a 100-person randomized trial, adults with post-COVID fatigue did 12 sessions of either immersive VR exercise or conventional exercise over six weeks. Both groups improved, but only the VR group crossed the threshold for a clinically meaningful fatigue reduction.
- Symptom worsening was also less common in the VR group (9% vs. 22%), and more VR participants reported overall improvement. Gains held at 12 months.
DNA Methylation Links Long COVID to Pulmonary Fibrosis Risk 🧬
- Whole-genome methylation sequencing across multiple Long COVID cohorts identified a shared epigenetic signature driven largely by T4 immune cells — and that signature overlaps with the epigenetic profile seen in patients at risk for pulmonary fibrosis.
- No prior study had compared Long COVID and fibrosis-associated epigenetic landscapes at this level, making the overlap a new and specific molecular connection between post-viral inflammation and fibrotic disease pathways.
2,900 Proteins, 21 Symptoms, Six Clusters — and Still No Single Long COVID Profile
- A proteomics study of 495 COVID-19 patients measured roughly 2,900 proteins and used machine learning to map which were associated with 15 post-COVID symptoms. The result: 235 unique proteins, six symptom clusters, and metabolic and inflammatory pathways running through most of them.
- Symptoms that shared similar protein profiles tended to co-occur in the same patients — suggesting the clustering is biologically real, not just coincidental grouping.
Brain Autoantibodies After COVID: Common, but Not the Culprit
- A study of 703 people tested several months after confirmed COVID infection found elevated autoantibody prevalence compared to pre-pandemic data — with antibodies against a brain receptor appearing at roughly twice the historical rate.
- The catch: autoantibody levels didn't differ between the 455 people who developed post-COVID syndrome and the 248 who fully recovered, and showed no relationship to symptom severity.
Six Inflammatory Clusters Inside Long COVID — Three Are Doing the Heavy Lifting 🔬
- Measuring 57 plasma biomarkers across 356 Long COVID patients, researchers used clustering to identify six distinct inflammatory profiles. Three were marked by elevated markers of tissue damage, coagulation, nerve injury, and antiviral immune activity.
- Those three 'highly inflamed' clusters were the ones associated with cardiovascular and respiratory symptoms — suggesting inflammation type, not just inflammation level, shapes which symptoms patients experience.
Your Genes May Shape Long COVID Risk — Through Inflammation and Clotting Markers
- In a study of 184 people, two HLA immune-gene variants were associated with Long COVID status: one allele appeared more often in Long COVID patients, another appeared less often. The associations held after adjustment for other variables.
- Mediation analysis suggested these genetic links may operate partly through C-reactive protein and an antibody linked to clotting risk — connecting inherited immune architecture to measurable inflammatory and coagulation signals.
Implications
The mechanistic picture of Long COVID is getting more precise — vascular dysfunction, epigenetic reprogramming, inflammatory subtypes — but precision is exposing a harder problem: most findings are associative, cohorts are small, and no single biomarker cleanly separates who develops Long COVID from who doesn't. The unresolved tension is whether these distinct biological subtypes require distinct treatments, or whether any intervention can work without first stratifying patients by mechanism.
Studies in this issue
Primary sources used for this newsletter.
- Ongoing blood vessel problems linked to reduced exercise ability in adults 3 years after COVID-19 despite normal heart functionmain storyPhysiological reports2026-09-29PMID 42810981
- Protein Patterns Linked to Long-Term Effects After COVID-19key findingMolecular & cellular proteomics : MCP2026-09-28PMID 42805392
- Brain-targeting auto-antibodies in people with and without long COVID after coronavirus infectionkey findingBrain, behavior, & immunity - health2026-10-01PMID 42819978
- DNA Methylation Patterns Associated with Long COVID Linked to T4 Immune Cells and Shared with Lung Scarring Riskkey findingJCI insight2026-09-29PMID 42809362
- Inflammation Patterns in People with Long COVIDkey findingJournal of immunology research2026-09-29PMID 42808678
- Using immersive virtual reality for digital rehabilitation of post-COVID fatigue in a double-blind trialkey findingPsychotherapy and psychosomatics2026-09-29PMID 42809480
- Certain HLA-DRB1 Genes and Long COVID: The Role of Antibodies and Inflammation Markerskey findingIranian journal of allergy, asthma, and immunology2026-10-02PMID 42825917
Continue reading
All Long Covid issuesGet the next Long Covid issue
Seven papers, once a week. Free.